These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1440649)

  • 1. IgG antibodies to Loxosceles sp. spider venom in human envenoming.
    Barbaro KC; Cardoso JL; Eickstedt VR; Mota I
    Toxicon; 1992 Sep; 30(9):1117-21. PubMed ID: 1440649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of the neutralizing capacity of horse antivenom against the Brazilian spider Loxosceles intermedia.
    Braz A; Minozzo J; Abreu JC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 1999 Sep; 37(9):1323-8. PubMed ID: 10400292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of recombinant antibody fragments with toxin-neutralizing potential in loxoscelism.
    Karim-Silva S; Moura Jd; Noiray M; Minozzo JC; Aubrey N; Alvarenga LM; Billiald P
    Immunol Lett; 2016 Aug; 176():90-6. PubMed ID: 27288291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
    Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
    Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of IgG(T) and IgGa isotypes obtained from arachnidic antivenom to neutralize toxic activities of Loxosceles gaucho, Phoneutria nigriventer and Tityus serrulatus venoms.
    Toro AF; Malta MB; Soares SL; Da Rocha GC; da Silva Lira M; De Oliveira TA; Takehara HA; Lopes-Ferreira M; Santoro ML; Guidolin R; Gondo Higashi H; Fernandes I; Barbaro KC
    Toxicon; 2006 Nov; 48(6):649-61. PubMed ID: 16979205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic cross-reactivity of venoms from medically important Loxosceles (Araneae) species in Brazil.
    Barbaro KC; Eickstedt VR; Mota I
    Toxicon; 1994 Jan; 32(1):113-20. PubMed ID: 9237343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dermonecrotic and lethal components of Loxosceles gaucho spider venom.
    Barbaro KC; Cardoso JL; Eickstedt VR; Mota I
    Toxicon; 1992 Mar; 30(3):331-8. PubMed ID: 1326796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of monoclonal antibodies capable of neutralizing dermonecrotic activity of Loxosceles intermedia spider venom and their use in a specific immunometric assay.
    Alvarenga LM; Martins MS; Moura JF; Kalapothakis E; Oliveira JC; Mangili OC; Granier C; Chávez-Olórtegui C
    Toxicon; 2003 Dec; 42(7):725-31. PubMed ID: 14757202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brown spider (Loxosceles genus) venom toxins: Evaluation of biological conservation by immune cross-reactivity.
    Buch DR; Souza FN; Meissner GO; Morgon AM; Gremski LH; Ferrer VP; Trevisan-Silva D; Matsubara FH; Boia-Ferreira M; Sade YB; Chaves-Moreira D; Gremski W; Veiga SS; Chaim OM; Senff-Ribeiro A
    Toxicon; 2015 Dec; 108():154-66. PubMed ID: 26474948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intradermal anti-loxosceles Fab fragments attenuate dermonecrotic arachnidism.
    Gomez HF; Miller MJ; Trachy JW; Marks RM; Warren JS
    Acad Emerg Med; 1999 Dec; 6(12):1195-202. PubMed ID: 10609920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
    Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
    Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISA for the detection of venom antigens in experimental and clinical envenoming by Loxosceles intermedia spiders.
    Chávez-Olórtegui C; Zanetti VC; Ferreira AP; Minozzo JC; Mangili OC; Gubert IC
    Toxicon; 1998 Apr; 36(4):563-9. PubMed ID: 9643469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivenom to the venom of the male Sydney funnel-web spider Atrax robustus: preliminary report.
    Sutherland SK
    Med J Aust; 1980 Oct; 2(8):437-41. PubMed ID: 7207323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards rationalisation of antivenom use in funnel-web spider envenoming: enzyme immunoassays for venom concentrations.
    Miller M; O'Leary MA; Isbister GK
    Clin Toxicol (Phila); 2016 Mar; 54(3):245-51. PubMed ID: 26678882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A protective vaccine against the toxic activities following Brown spider accidents based on recombinant mutated phospholipases D as antigens.
    Polli NLC; Justa HCD; Antunes BC; Silva TPD; Dittrich RL; de Souza GS; Wille ACM; Matsubara FH; Minozzo JC; Mariutti RB; Arni RK; Senff-Ribeiro A; Veiga SS; Gremski LH
    Int J Biol Macromol; 2021 Dec; 192():757-770. PubMed ID: 34634338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.
    Karim-Silva S; Becker-Finco A; Jiacomini IG; Boursin F; Leroy A; Noiray M; de Moura J; Aubrey N; Billiald P; Alvarenga LM
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32316084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunodetection of the "brown" spider (Loxosceles intermedia) dermonecrotoxin with an scFv-alkaline phosphatase fusion protein.
    Jiacomini I; Silva SK; Aubrey N; Muzard J; Chavez-Olortegui C; De Moura J; Billiald P; Alvarenga LM
    Immunol Lett; 2016 May; 173():1-6. PubMed ID: 26970375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and neutralization of biological activities in the venoms of Loxosceles spiders.
    Barbaro KC; Ferreira ML; Cardoso DF; Eickstedt VR; Mota I
    Braz J Med Biol Res; 1996 Nov; 29(11):1491-7. PubMed ID: 9196551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.